Your session is about to expire
← Back to Search
Cannabinoid
Cannabidiol (1 dose) for Diet Modification
Phase < 1
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Summary
Cannabidiol (CBD) is a bioactive cannabinoid compound in marijuana (cannabis sativa), but unlike Δ9 tetrahydrocannabinol (THC), lacks the psychoactivity effect of THC. Available evidence suggests that there are marked therapeutic CBD effects for diverse disease processes including inflammation, cancers, psychosis, and epileptic seizures. The purpose of this study, in both younger and older healthy humans, is to improve our understanding of how CBD might control and regulate blood vessel health as well as cognitive and exercise performance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Circulating cannabidiol and nitric oxide markers
Vascular function
Secondary outcome measures
Anxiety Questionnaire
Body mass index
Cognitive performance
+9 moreTrial Design
5Treatment groups
Active Control
Placebo Group
Group I: Cannabidiol (1 dose)Active Control1 Intervention
Only cannabidiol supplement.
Group II: Cannabidiol and herbal capsules (2 dose)Active Control1 Intervention
Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.
Group III: Cannabidiol only (2 dose)Active Control1 Intervention
Only cannabidiol supplement.
Group IV: Cannabidiol and herbal capsules (1 dose)Active Control1 Intervention
Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.
Group V: PlaceboPlacebo Group1 Intervention
Sugar pill that will have no effect.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,431 Previous Clinical Trials
2,478,879 Total Patients Enrolled
4 Trials studying Diet Modification
461 Patients Enrolled for Diet Modification
Lexaria Bioscoence CorpUNKNOWN
Share this study with friends
Copy Link
Messenger